All News

The FDA has granted a fast track designation to devimistat (CPI-613) for the treatment of patients with acute myeloid leukemia.

Study aims to increase patient access to clinical care delivered in community pharmacies by leveraging the expanded roles of pharmacy technicians.

Tirbanibulin is expected to be launched in the United States during the first quarter of 2021.

Among a subset of participants in the COVID-19 vaccine clinical trials, 0.63% of individuals in the vaccinated group had hypersensitivity-related adverse events that may represent allergic reactions.

Under the 340B Prime Vendor Program, the Prime Vendor has several functions that it carries out to support stakeholders in operating and navigate the field so that they can effectively achieve lower 340B drug pricing for those who need it most.

Financial toxicity can lead to worse long-term outcomes and psychological distress among patients with breast cancer.

The FDA is expected to review the safety and efficacy data package from Moderna's COVID-19 vaccine candidate on December 17, which could lead to an EUA being issued this week.

As administration of COVID-19 begins, pharmacies are preparing to vaccinate millions of people, not only once but twice.

Learn how you and your staff can help patients differentiate between common cough/cold symptoms and COVID-19 while also offering additional educational resources.

Study shows the mortality rate among breast cancer survivors is lower among those who received fertility preservation.

This week on Pharmacy Times, there are a number of important topics that will be covered and posted throughout the week.

The papers in the special issue highlight the research team’s focus on understanding the experiences of caregivers of persons with TBI and illustrate the team’s ability to efficiently capture those experiences through a tool known as TBI-CareQOL Measurement System.

Individuals who reported zero or fewer live births and those who reported many live births had markers of quicker aging than those who reported 3 or 4 births.

The cost of oncology treatment is high and rising in the United States.

Distribution of the first 2.9 million doses of the COVID--19 vaccine jointly developed by Pfizer and BioNTech are expected to begin within hours of the FDA’s decision.

A member of the FDA’s expert advisory committee who voted in favor of Pfizer and BioNTech’s COVID-19 vaccine said that distribution of the first vaccines to high priority populations in the United States could begin as early as Monday.

Genetic predisposition is only part of the pre-eclampsia risk.

Medication nonadherence results in greater health care spending and poorer patient health outcomes.

Paracelsus referred to the drug as the “stone of immortality,” which may have been the impetus for his fine-tuning it further. Later, Thomas Sydenham created his own version in the 1600s with the important addition of alcohol.

Supreme Court decision establishes that states do have the right to regulate pharmacy benefit managers in managed care organizations.

Direct-to-consumer COVID-19 kit allows for anyone over 18 years of age to perform a nasal swab on themselves and send the sample off for testing.

Variability in prescrption handoffs might make the difference between a patient who is adherent or not.

An icatibant injection has been released in the United States as an alternative treatment for acute attacks of hereditary angioedema in adults over the age of 18 years.

Cinacalcet Tablets are used to treat hyperparathyroidism (overactive functioning of the parathyroid glands) in people who are on long-term dialysis for kidney disease.

Younger and Black patients are more likely to experience breast cancer symptom under-recognition.

If current drug pricing trends continue, cost-related non-adherence to therapy will result in the premature deaths of 112,000 Medicare beneficiaries per year.

A new combination therapy cleanses the colon before this important procedure that screens for colorectal cancer, the third-leading cause of cancer-related deaths in the United States.

The tau protein can help identify Alzheimer disease before cognitive decline begins.